DEFITELIO 80 mg/mL
- Name: DEFITELIO
- Generic Name: Defibrotide
- Strength: 80 mg, 200 mg in 2.5 mL
- Manufactured: GlaxoSmithKline.
- Defibrotide was approved in Europe in 2013 and three years later in the US (2016).
- Defibrotide was approved in Europe in 2013 and three years later in the US (2016).
- This drug should be avoided in people who have a difficult time maintaining a steady blood pressure.
- Defibrotide should be administered by intravenous infusion in a doctor’s office or clinic.
- Pregnant women must avoid the consumption of defibrotide.
What is hepatic veno-occlusive: The hepatic veno-occlusive disease known as veno-occlusive disease with immunodeficiency (VODI). It is basically a potentially life-threatening condition in which some of the small veins in the liver are obstructed. VODI, a kind of complication of high-dose chemotherapy given prior to the bone marrow transplant (BMT) or excessive exposure to hepatotoxic pyrrolizidine alkaloids.
What causes veno occlusive disease?
VODI occurs as a result of the chemotherapy or bone marrow transplantation. Apart from chemotherapy, veno occlusive disease with immunodeficiency can also occur after the ingestion of the certain plant alkaloids for instance pyrrolizidine alkaloids (in some herbal teas), and has been specified as a part of the rare hereditary disease addressed as the hepatic veno occlusive disease with immunodeficiency.
What is defibrotide used for?
Defibrotide 200 mg is used to treat veno-occlusive disease of the liver of people having had a bone marrow transplant.
Defibrotide availability: Defibrotide is available at every legitimate pharmaceutical company or wholesaler. For hepatic veno-occlusive treatment, this drug can be purchased by any respective patient after getting a valid prescription from their healthcare provider.
How does an order will be confirmed?
How does an order will be confirmed?The order only can be confirmed after the receipt of
- Valid prescription of Oncologist
- Import permit (if required)
What is the Generic Name for the trade name drug Defibrotide ?
Defibrotide is Generic Name for the trade name drug Defitelio
What is the Manufacturer Name of Defibrotide?
Defibrotide is manufactured by Gentium SpA.
Is Defibrotide approved by FDA?
Yes, Defibrotide is approved by FDA. Date of approval: March 2016
What is the dosage and form of Defibrotide is available?
One mL contains defibrotide 80 mg corresponding to a quantity of 200 mg in 2.5 mL in a vial and corresponding to a concentration in the range of 4 mg/mL to 20 mg/mL after dilution
What is the Highlights of prescribing information of Defibrotide?
Click Here to download full prescribing information.
Indian Pharma Network is able to source DEFIBROTIDE (Cancer Treatment Medicines) from across the globe, and has ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to Patient’s address only from New Delhi, India.
- that has spread to other parts of the body or cannot be removed by surgery, and
- Chronic lymphocytic leukemia (CLL) with 17p deletion
- that has a certain type of abnormal “BRAF” gene.
- Valid prescription of Oncologist
- Import permit if applicable
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.